Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Ipca Laboratories Ltd.
NSE: IPCALAB
|
BSE: 524494
|
ISIN: INE571A01038
|
Industry: Pharmaceuticals
Estimates Miss
|
Expensive Performer
1424.8000
-45.20
(
-3.07
%)
NSE
May 30, 2025
15:31 PM
35.44% Gain from 52W Low
Volume:
331.0K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Ipca Laboratories Ltd.
22 Oct 2023
Estimates Miss
1424.80
-3.07%
Clearance of Ratlam API site to uplift the US prospects
Neutral:
Ipca Laboratories Ltd.
by
Motilal Oswal
Target: 860
Target
Motilal Oswal
Number of FII/FPI investors increased from 282 to 294 in Mar 2025 qtr.
More from Ipca Laboratories Ltd.
Recommended
Five Interesting Stocks Today - May 30, 2025
The Baseline |
30 May 2025, 05:44PM
Market closes lower, Lemon Tree Hotels' Q4 net profit beats Forecaster estimates by 13.5%
Trendlyne Marketwatch |
30 May 2025, 03:54PM
IPCA Labs’ domestic formulations business to drive growth
|
05 Jul 2021